Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8447606 | European Journal of Cancer | 2011 | 9 Pages |
Abstract
Overall, our clinical data are in contrast with the assumption that higher amounts of IGF/IGF-IR are a surrogate for higher aggressiveness and indicate that in some cancers the transition to frank malignancy and poor treatment responsiveness seem to be associated with a reduction of IGF system activity.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Katia Scotlandi, Maria Cristina Manara, Massimo Serra, Maria Teresa Marino, Selena Ventura, Cecilia Garofalo, Marco Alberghini, Giovanna Magagnoli, Stefano Ferrari, Jose Antonio Lopez-Guerrero, Antonio Llombard-Bosch, Piero Picci,